Page last updated: 2024-10-24

carmustine and FMR1-Related Primary Ovarian Insufficiency

carmustine has been researched along with FMR1-Related Primary Ovarian Insufficiency in 2 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chatterjee, R2
Mills, W1
Katz, M1
McGarrigle, HH1
Goldstone, AH2
Salooja, N1
McMillan, AK1
Kelsey, SM1
Newland, AC1
Milligan, DW1
Franklin, IM1
Hutchinson, RM1
Linch, DC1

Other Studies

2 other studies available for carmustine and FMR1-Related Primary Ovarian Insufficiency

ArticleYear
Induction of ovarian function by using short-term human menopausal gonadotrophin in patients with ovarian failure following cytotoxic chemotherapy for haematological malignancy.
    Leukemia & lymphoma, 1993, Volume: 10, Issue:4-5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmu

1993
Successful pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocol.
    Bone marrow transplantation, 1994, Volume: 13, Issue:4

    Topics: Abortion, Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantatio

1994